This Week in Nature

In this week's Nature, a team led by scientists from the National Cancer Institute reports on the discovery of genes that are required for certain cancer immunotherapies to be effective and which contribute to drug-resistant tumors. Using a genome-scale CRISPR/Cas9 screen, the team profiled genes whose loss in tumor cells impaired the effector function of CD8-positive T cells (EFT).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.